Tumor infiltrating lymphocytes in primary breast cancer (TIL) are acknowledged measures of disease free survival (DFS) in adjuvant and neoadjuvant settings. Little is known about the biology of metastasis infiltrating lymphocytes (mTIL) although the local immunity of the metastatic site may critically influence the infiltrate composite. To address this question we compared mTIL with their matched TIL in 87 breast cancer patients and their corresponding distant metastasis at four different anatomical locations. Sections of surgical specimen were immunohistochemically analyzed for CD4, CD8 and CD20 positive lymphocytes in three different tumor compartments: intratumoral lymphocytes (iTIL) defined as lymphocytes in direct contact with breast c...
In recent years, results obtained from different studies with large cohorts have revealed a bond bet...
Abstract Tumor infiltrating lymphocytes (TILs) are commonly detected in breast tumors but their bear...
BACKGROUND: Tumor infiltrating lymphocytes (TILs) were evaluated in many cancers like ovarian tumo...
Tumor infiltrating lymphocytes (TILs) were evaluated in many cancers like ovarian tumors, endometria...
Abstract Background Tumor-infiltrating lymphocytes (TILs) are described as an important immune modul...
Introduction: Tumor infiltrating lymphocytes may indicate an immune response to can...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
Twenty-nine patients with cancer of the breast were examined immunohistopathologically as to the res...
The clinical relevance of tumor-infiltrating lymphocytes (TIL) in breast cancer (BC) has been clearl...
Background: Patients diagnosed with metastatic breast cancer have poor outcome with a median surviva...
Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly i...
While breast cancer has not been considered a cancer amenable to immunotherapeutic approaches, recen...
The recent success of the immune checkpoint blockade in cancer immunotherapy has modified the treatm...
Breast cancer has not previously been considered a highly immunogenic cancer. Observations of tumour...
In recent years, results obtained from different studies with large cohorts have revealed a bond bet...
Abstract Tumor infiltrating lymphocytes (TILs) are commonly detected in breast tumors but their bear...
BACKGROUND: Tumor infiltrating lymphocytes (TILs) were evaluated in many cancers like ovarian tumo...
Tumor infiltrating lymphocytes (TILs) were evaluated in many cancers like ovarian tumors, endometria...
Abstract Background Tumor-infiltrating lymphocytes (TILs) are described as an important immune modul...
Introduction: Tumor infiltrating lymphocytes may indicate an immune response to can...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
In breast cancer (BC), the development of cancer immunotherapy including immune checkpoint inhibitor...
Twenty-nine patients with cancer of the breast were examined immunohistopathologically as to the res...
The clinical relevance of tumor-infiltrating lymphocytes (TIL) in breast cancer (BC) has been clearl...
Background: Patients diagnosed with metastatic breast cancer have poor outcome with a median surviva...
Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly i...
While breast cancer has not been considered a cancer amenable to immunotherapeutic approaches, recen...
The recent success of the immune checkpoint blockade in cancer immunotherapy has modified the treatm...
Breast cancer has not previously been considered a highly immunogenic cancer. Observations of tumour...
In recent years, results obtained from different studies with large cohorts have revealed a bond bet...
Abstract Tumor infiltrating lymphocytes (TILs) are commonly detected in breast tumors but their bear...
BACKGROUND: Tumor infiltrating lymphocytes (TILs) were evaluated in many cancers like ovarian tumo...